What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Immune system
Jan Buer mostly deals with Cell biology, Immunology, Cytotoxic T cell, IL-2 receptor and T cell.
His research integrates issues of Acquired immune system, Genetics, Dendritic cell, Antigen and Cell cycle in his study of Cell biology.
His study on Immunology is mostly dedicated to connecting different topics, such as Microbiology.
His Microbiology study incorporates themes from Virulence factor, Virulence, Colitis and Bacteria.
His study in IL-2 receptor is interdisciplinary in nature, drawing from both CD28 and Interleukin 21.
In his research, Lymphokine-activated killer cell and Interleukin 12 is intimately related to Antigen-presenting cell, which falls under the overarching field of Interleukin 21.
His most cited work include:
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. (1267 citations)
- Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset (929 citations)
- Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota (747 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Microbiology, Cell biology, Immune system and T cell.
His study in Immunology concentrates on IL-2 receptor, FOXP3, Antigen, Inflammation and CD8.
In IL-2 receptor, Jan Buer works on issues like Interleukin 21, which are connected to Natural killer T cell.
The concepts of his Microbiology study are interwoven with issues in Biofilm, Cystic fibrosis, Pseudomonas aeruginosa and Gene, Virulence.
His research in Cell biology intersects with topics in CD28 and T-cell receptor.
His Immune system research integrates issues from Receptor, In vitro and In vivo.
He most often published in these fields:
- Immunology (35.44%)
- Microbiology (20.25%)
- Cell biology (17.09%)
What were the highlights of his more recent work (between 2018-2021)?
- Immune system (16.77%)
- Microbiology (20.25%)
- Immunology (35.44%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Immune system, Microbiology, Immunology, T cell and Cancer research.
His Microbiology research is multidisciplinary, incorporating perspectives in Pseudomonas aeruginosa, Sphingosine and Biofilm.
His biological study focuses on Bone marrow.
His T cell research is multidisciplinary, relying on both Methadone, Cytotoxic T cell, CD8 and Cytokine.
His studies in Cancer research integrate themes in fields like Cancer, Colorectal cancer and Gene expression.
His FOXP3 research is multidisciplinary, incorporating elements of Molecular biology, Intestinal mucosa and Gene.
Between 2018 and 2021, his most popular works were:
- The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer (39 citations)
- Gut Microbiota in Human Immunodeficiency Virus–Infected Individuals Linked to Coronary Heart Disease (15 citations)
- A Tumor-Peptide–Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy (11 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Immune system
Jan Buer mainly investigates Immune system, Microbiology, FOXP3, T cell and Cancer research.
His studies deal with areas such as Cytotoxic T cell and Gut flora as well as Immune system.
The Microbiology study combines topics in areas such as Inflammation, Staphylococcus epidermidis, Drug and Biofilm.
Jan Buer combines subjects such as Tumor microenvironment, Intestinal mucosa and Gene with his study of FOXP3.
His study looks at the relationship between T cell and topics such as In vitro, which overlap with Endogeny, Molecular biology, CD11c and Gene expression.
His CD8 study combines topics in areas such as Antigen-presenting cell, Interleukin, Interleukin 33, Cell biology and Regulatory T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
